Evaluating screening policies for the early detection of retinopathy in patients with non-insulin dependent diabetes

被引：17

作者：

Brailsford S.C. ^{[1
]}

Davies R. ^{[1
]}

Canning C. ^{[2
]}

Roderick P.J. ^{[3
]}

机构：

[1] School of Management, University of Southampton

[2] Southampton Eye Unit, Southampton University Hospitals Trust

[3] Wessex Institute of Health Research and Development, University of Southampton

来源：

Health Care Management Science | 1998年 / 1卷 / 2期

关键词：

Diabetic Retinopathy; Blindness; Diabetic Macular Oedema; Proliferative Diabetic Retinopathy; Annual Probability;

D O I：

10.1023/A:1019086300747

中图分类号：

学科分类号：

摘要：

Retinopathy is a common complication of insulin-dependent (IDDM) and non-insulin-dependent (NIDDM) diabetes, but serious visual loss may be prevented or delayed with sufficiently early diagnosis and treatment. Screening for early signs of retinopathy is clearly beneficial for some people, but there is no established consensus about who should be screened, by whom, by what technique and with what frequency, especially for NIDDM. The model described in this paper simulates the development of eye disease in a population of NIDDM patients and the effects of different screening schemes in terms of years of sight saved and the numbers of people prevented from suffering severe visual loss. The initial results indicate that blanket screening of all NIDDM patients may not be effective. © Baltzer Science Publishers BV.

引用

页码：115 / 124

页数：9

共 44 条

[1]

Agardh E., Et al., Four-year incidence of diabetic retinopathy in older onset diabetes mellitus, Diabetic Medicine, 11, pp. 273-278, (1993)

[2]

Bachmann M., Nelson S., Screening for Diabetic Retinopathy: A Quantitative Overview of the Evidence, Applied to the Populations of Health Authorities and Boards, (1996)

[3]

Ballard D.J., Et al., Risk factors for diabetic retinopathy: A population-based study in Rochester, Minnesota, Diabetes Care, 9, pp. 334-342, (1986)

[4]

Barrie T., Et al., The role of optometrists in the screening for diabetic eye disease in the community, Royal College of Ophthalmologists Meeting, (1995)

[5]

Borland Delphi, (1997)

[6]

Photocoagulation for proliferative diabetic retinopathy: A randomised controlled trial using the xenon arc, Diabetologia, 26, pp. 109-115, (1984)

[7]

Photocoagulation for diabetic retinopathy: A randomised controlled trial using the xenon arc, Diabetes, 32, pp. 1010-1016, (1984)

[8]

Croxson S.C.M., Et al., The prevalence of diabetes in elderly people, Diabetic Medicine, 8, pp. 28-31, (1991)

[9]

Davies R., Davies H.T.O., Modelling patient flows and resource provision in health systems, Omega International Journal of Management Science, 22, pp. 123-131, (1994)

[10]

Davies R., Sullivan P., Canning C.R., Simulation of diabetic eye disease to compare screening policies, British Journal of Ophthalmology, 80, pp. 945-950, (1996)

← 1 2 3 4 5 →